Tóm tắt
Digoxin: Nhìn lại từ một thuốc đã cũ
Trang chủ
CHUYÊN ĐỀ
Số phát hành:
Digoxin: Nhìn lại từ một thuốc đã cũ
Phạm Như Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Xuất bản: tháng 8 1, 2014
Views: 1
Tài liệu tham khảo
1.
1. WHO model list of esstial Medicine. April 2013. http://www.who.int/medicines/publications/ essentialmedicines/en/index.
2.
2. Hollman A. Digoxin comes from Digitalis Ianata. Brishtish medical Journal 1996; 312: 912.
3.
3. Kelly RA, Smith TW. Digoxin in heart failure: Implications of recent trials. J Am Coll Cardiol 1993; 22: 107A-112 A.
4.
4. The Digitalis Investigation Group. The effect of digoxin on mortality and morbility in pts with heart failure.
5.
N Engl J Med 1997; 336: 525-533.
6.
5. Swedberg K, Komajda M, Boăhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo- controlled study. Lancet 2010;376:875-885.
7.
6. LechatP, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H, the CIBIS II Investigators. Heart rate cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001 103:1428-1433.
8.
7. GullestadL, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol 2005; 45:252-259.
9.
8. DiBianco R, Shabetai R, Kostuk E et al for the Milrinone Multicentre Trial Group. A comparison of oral milrrinone,digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320:677-683.
10.
9. The German and Austrian Xamoterol Study Group. Double- blind placebo controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988; 1:489-493.
11.
10. Uretsky BF, Young JB, Shahidi FE et al. the PROVED Investigative Group. Randomized study assesing the effect of digoxin withdrawal in pts with mild to moderate chronic congestive heart failure results of the PROVED Trial. J Am Coll Cardiol 1993; 22:955-962.
12.
11. Packer M, Gheorghiade M, Young JB et al. Withdrawal of digoxin from the pts with chronic heart failure
13.
treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7.
14.
12. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure:
15.
Circulation. 2013; 128: e240-e327.
16.
13. Yusuf S, Negassa A. Choice of clinical outcomes in randomized trials of heart failure therapies: disease- specific or overall outcomes? Am Heart J 2002;143:22-28.
17.
14. Rahimtoola SH. Digitalis therapy for patients in clinical heart failure. Circulation 2004;109:2942-2946.
18.
15. Watanabe AM. Digitalis and the autonomic nervous system. J Am Coll Cardiol 1985;5(Suppl A):35A- 42A.
19.
16. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
20.
17.M van Veldhuisen DJ, Man in ’t Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993;22:1564-1573.
21.
18. Brouwer J, van Veldhuisen DJ, Man in ’t Veld AJ, Dunselman PH, Boomsma F, Haaksma J, Lie KI. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. J Am Coll Cardiol 1995;26:983-990.
22.
19. Krum H, Bigger JT Jr, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-294.
23.
20. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-1213
24.
21. Khand AU, Rankin AC, Martin W, Taylor J, Gemmell I, Cleland JG. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 2003;42:1944-1951.
25.
22. Tardif JC, O’Meara E, Komajda M, Boăhm M, Borer JS, Ford I, Tavazzi L, Swedberg K; on behalf of the SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J 2011.
26.
23. Cullington D, Goode KM, Cleland JG, Clark AL. Limited role for Ivabradine in the treatment of chronic heart failure. Heart 2011;97:1961-1966.